KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medpace Holdings (MEDP) Invested Capital (2016 - 2025)

Medpace Holdings' Invested Capital history spans 11 years, with the latest figure at $459.1 million for Q4 2025.

  • For Q4 2025, Invested Capital fell 44.39% year-over-year to $459.1 million; the TTM value through Dec 2025 reached $459.1 million, down 44.39%, while the annual FY2025 figure was $459.1 million, 44.39% down from the prior year.
  • Invested Capital reached $459.1 million in Q4 2025 per MEDP's latest filing, up from $293.6 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $952.9 million in Q4 2021 to a low of $172.4 million in Q2 2025.
  • Average Invested Capital over 5 years is $611.2 million, with a median of $576.3 million recorded in 2023.
  • Peak YoY movement for Invested Capital: soared 87.18% in 2024, then tumbled 77.43% in 2025.
  • A 5-year view of Invested Capital shows it stood at $952.9 million in 2021, then tumbled by 54.21% to $436.4 million in 2022, then grew by 28.09% to $558.9 million in 2023, then surged by 47.7% to $825.5 million in 2024, then tumbled by 44.39% to $459.1 million in 2025.
  • Per Business Quant, the three most recent readings for MEDP's Invested Capital are $459.1 million (Q4 2025), $293.6 million (Q3 2025), and $172.4 million (Q2 2025).